nivolumab,ipilimumab
bms
['congrat', '/ipi', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'nivo', 'niche-2']
 new soc niche-2 included 107 patients 95% mpr &amp; 67% pcr with neoadjuvant nivo/ipi in dmmr stage ii/iii crc 6 w of treatment alone. 100% achieved r0 surgery look at these forest plots! congrats !!!
#esmo22 #immunotherapy 
Medical Oncologist| Medical Educator| @annualsdui SDUI 2017-2020|????????